These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35435140)

  • 41. Early resolution of type 2 diabetes seen after Roux-en-Y gastric bypass and vertical sleeve gastrectomy.
    Bayham BE; Greenway FL; Bellanger DE; O'Neil CE
    Diabetes Technol Ther; 2012 Jan; 14(1):30-4. PubMed ID: 21933001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone Health in Patients with Type 2 Diabetes Treated by Roux-En-Y Gastric Bypass and the Role of Diabetes Remission.
    Madsen LR; Espersen R; Ornstrup MJ; Jørgensen NR; Langdahl BL; Richelsen B
    Obes Surg; 2019 Jun; 29(6):1823-1831. PubMed ID: 30719648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors determining chance of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a nationwide cohort study in 8057 Swedish patients.
    Stenberg E; Olbers T; Cao Y; Sundbom M; Jans A; Ottosson J; Naslund E; Näslund I
    BMJ Open Diabetes Res Care; 2021 May; 9(1):. PubMed ID: 33990366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-Utility of Laparoscopic Roux-en-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes and Obesity with a BMI ≥ 27.5 kg/m2: a Multi-Center Study with a 4-Year Follow-Up of Surgical Cohort.
    Tu Y; Wang L; Wei L; Xu Y; Han X; Han J; Yu H; Zheng C; Bao Y; Jia W
    Obes Surg; 2019 Dec; 29(12):3978-3986. PubMed ID: 31338737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A 7-Year Clinical Audit of 1107 Cases Comparing Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and Mini-Gastric Bypass, to Determine an Effective and Safe Bariatric and Metabolic Procedure.
    Jammu GS; Sharma R
    Obes Surg; 2016 May; 26(5):926-32. PubMed ID: 26337694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters.
    Graessler J; Qin Y; Zhong H; Zhang J; Licinio J; Wong ML; Xu A; Chavakis T; Bornstein AB; Ehrhart-Bornstein M; Lamounier-Zepter V; Lohmann T; Wolf T; Bornstein SR
    Pharmacogenomics J; 2013 Dec; 13(6):514-22. PubMed ID: 23032991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pros and cons of Roux en-Y gastric bypass surgery in obese patients with type 2 diabetes.
    Justinussen T; Madsbad S; Holst JJ; Bojsen-Møller KN
    Expert Rev Endocrinol Metab; 2019 Jul; 14(4):243-257. PubMed ID: 31215828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of weight regain in patients who underwent Roux-en-Y gastric bypass surgery.
    Shantavasinkul PC; Omotosho P; Corsino L; Portenier D; Torquati A
    Surg Obes Relat Dis; 2016 Nov; 12(9):1640-1645. PubMed ID: 27989521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study.
    De Bandt D; Rives-Lange C; Frigout Y; Bergerot D; Blanchard A; Le Gall M; Lacorte JM; Chevallier JM; Czernichow S; Poghosyan T; Carette C; Le Beyec J
    Obes Surg; 2022 Mar; 32(3):757-762. PubMed ID: 34993850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Analysis of Mid-Term Complications, Weight Loss, and Type 2 Diabetes Resolution of Stomach Intestinal Pylorus-Sparing Surgery (SIPS) Versus Roux-En-Y Gastric Bypass (RYGB) with Three-Year Follow-Up.
    Cottam A; Cottam D; Zaveri H; Cottam S; Surve A; Medlin W; Richards C
    Obes Surg; 2018 Sep; 28(9):2894-2902. PubMed ID: 29790130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Roux-en-Y Gastric Bypass Improved Insulin Resistance via Alteration of the Human Gut Microbiome and Alleviation of Endotoxemia.
    Shi Q; Wang Q; Zhong H; Li D; Yu S; Yang H; Wang C; Yin Z
    Biomed Res Int; 2021; 2021():5554991. PubMed ID: 34337024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy for Remission of Type 2 Diabetes.
    Castellana M; Procino F; Biacchi E; Zupo R; Lampignano L; Castellana F; Sardone R; Palermo A; Cesareo R; Trimboli P; Giannelli G
    J Clin Endocrinol Metab; 2021 Mar; 106(3):922-933. PubMed ID: 33051679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities.
    Ruiz-Tovar J; Carbajo MA; Jimenez JM; Castro MJ; Gonzalez G; Ortiz-de-Solorzano J; Zubiaga L
    Surg Endosc; 2019 Feb; 33(2):401-410. PubMed ID: 29943058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of Roux-en-Y gastric bypass or diabetes support and education on insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes.
    Khoo CM; Chen J; Pamuklar Z; Torquati A
    Ann Surg; 2014 Mar; 259(3):494-501. PubMed ID: 23732262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating magnesium status is associated with type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a long-term cohort study.
    Haenni A; Nilsen I
    Surg Obes Relat Dis; 2021 Feb; 17(2):299-307. PubMed ID: 33153966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increase of the Adiponectin/Leptin Ratio in Patients with Obesity and Type 2 Diabetes after Roux-en-Y Gastric Bypass.
    Unamuno X; Izaguirre M; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Becerril S; Valentí V; Moncada R; Silva C; Salvador J; Portincasa P; Frühbeck G; Catalán V
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31484347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Banded Roux-en-Y gastric bypass in patients with super morbid obesity (BRandY-study): protocol of a cohort study with 10 year follow-up.
    Romeijn MM; Leclercq WKG; Luijten AAPM; Janssen L; van Dielen FMH
    BMC Surg; 2020 Jun; 20(1):122. PubMed ID: 32503510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
    Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
    Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Effect of Gastric Bypass with a Distal Gastric Pouch on Glucose Tolerance and Diabetes Remission in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Shao Y; Li C; Zhu X; Yao L; Wang H
    Obes Surg; 2019 Jun; 29(6):1889-1900. PubMed ID: 30778846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes.
    Kong LC; Tap J; Aron-Wisnewsky J; Pelloux V; Basdevant A; Bouillot JL; Zucker JD; Doré J; Clément K
    Am J Clin Nutr; 2013 Jul; 98(1):16-24. PubMed ID: 23719559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.